Cargando...
Immune-based therapies in acute leukemia
Treatment resistance remains a leading cause of acute leukemia -related deaths. Thus, there is an unmet need to develop novel approaches to improve outcome. New immune-based therapies with chimeric antigen receptor (CAR) T cells, bi-specific T cell engagers (BiTEs) and immune checkpoint blockers (IC...
Guardado en:
| Publicado en: | Trends Cancer |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859901/ https://ncbi.nlm.nih.gov/pubmed/31706508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2019.07.009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|